Daijiro Harada - Shikoku Cancer Center

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 94 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Baseline Genetic Abnormalities and Effectiveness of Osimertinib Treatment in Patients with Chemotherapy-Naïve EGFR-mutated NSCLC Based on Performance Status

Yoshihiko Taniguchi,Akihiro Tamiya,Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa, Keiichi Nakamura,Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

BMC Pulmonary Medicineno. 1 (2024): 1-6

Cited0Views0WOSBibtex

Mechanisms of Resistance and Correlation Between Pre-Treatment Co-Alterations and P-Prognosis to Osimertinib in Chemo-Naïve Advanced Non-Small Cell Lung Cancer

Akihiro Tamiya, Mitsuo Osuga,Daijiro Harada,Shun-ichi Isa, Yoshihiko Taniguchi,Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara,Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori,Tomohito Kuwako,Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

LUNG CANCER (2024)

Cited0Views0WOSBibtex

Abstract 964: Updated results of a prospective observational multicenter study on resistance mechanisms to osimertinib using circulating tumor DNA analyses in EGFR-mutated non-small cell lung cancer patients (ELUCIDATOR study)

Mitsuo Osuga,Akihiro Tamiya,Daijiro Harada,Yasuyuki Mizumori,Shun-ichi Isa,Yoshihiko Taniguchi, Keiichi Nakamura, Tsutomu Shinohara,Hidetoshi Yanai,Katsumi Nakatomi,Masahide Oki,Masahide Mori, Tomohito Kuwako, Koji Yamazaki,Atsuhisa Tamura,Masahiko Ando,Yasuhiro Koh

Cancer Researchno. 6_Supplement (2024): 964-964

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn